$ISIS News Health-care-related stocks keep on gi
Post# of 72741
Posted On: 02/26/2014 10:58:14 AM
$ISIS News
Health-care-related stocks keep on giving 12:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 12:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 11:59 a.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 10:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 2:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 9:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 10:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 2:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 10:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 4:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 5:18 p.m. June 25, 2013 - Russ Britt
Dissecting the close: Isis soars on data, while Pfizer loses on spin-off 6:26 p.m. June 24, 2013 - Russ Britt
3 ways to play the biotech boom 6:01 a.m. June 3, 2013 - Jeff Reeves
S&P 500 holds the 50-day average — barely 10:41 a.m. April 18, 2013 - Michael Ashbaugh
Biogen inks drug-development deal with Isis 2:06 p.m. Dec. 10, 2012 - MarketWatch.com
Isis: progress in early-stage study of cancer drug 7:53 a.m. Oct. 31, 2012 - MarketWatch.com
Isis Pharma rises 9% in premarket 6:22 a.m. Oct. 19, 2012 - Steve Gelsi
Investing in ‘junk DNA’ 9:28 p.m. Sept. 11, 2012 - Jen Wieczner
Growth Stocks: 7 Rallying Stocks With No Profits (Yeta????) 5:51 p.m. Feb. 24, 2014 - TheStreet.com
Isis Pharma Soars on Positive Data - Analyst Blog 1:30 p.m. Feb. 24, 2014 - Zacks.com
ISIS reiterated a Buy at Deutsche after data 11:03 a.m. Feb. 21, 2014 - Seeking Alpha
Isis therapy for spinal muscular atrophy provides encouraging results 7:41 a.m. Feb. 21, 2014 - Seeking Alpha
Isis Pharmaceuticals (ISIS): Today's Featured Drugs Laggard 5:01 p.m. Feb. 18, 2014 - TheStreet.com
Positive Opinion on Isis Pharma's ISIS-TTRRx - Analyst Blog 11:50 a.m. Feb. 18, 2014 - Zacks.com
Isis to get another $9M from Biogen 9:15 a.m. Feb. 13, 2014 - Seeking Alpha
Canadian Nod for Aegerion's Juxtapid - Analyst Blog 4:45 p.m. Feb. 11, 2014 - Zacks.com
OncoGenex Has A Potential Blockbuster Drug, But The Markets Are Pricing It Like An Orphan 9:25 a.m. Jan. 28, 2014 - Seeking Alpha
Jim Cramer's Top Stock Picks: ISIS JAZZ SYY ETH IBM 6:00 a.m. Jan. 28, 2014 - TheStreet.com
Cramer's Mad Money - We Are In Reset Mode (1/27/14) 5:06 a.m. Jan. 28, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Market Reset 8:33 p.m. Jan. 27, 2014 - TheStreet.com
Insider Trading Alert - PLUG, UNP, OPK, ISIS And MA Traded By Insiders 10:03 a.m. Jan. 27, 2014 - TheStreet.com
Mexican Approval for Aegerion's Juxtapid - Analyst Blog 4:20 p.m. Jan. 21, 2014 - Zacks.com
Isis Pharmaceuticals, Inc. (ISIS): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 21, 2014 - Zacks.com
Isis, Teledyne and Pandora Among Top Small-Cap Picks 6:00 a.m. Jan. 16, 2014 - TheStreet.com
Isis Pharma gets $7.5M from Alnylam 4:47 p.m. Jan. 13, 2014 - Seeking Alpha
New Lifetime High For Isis Pharmaceuticals (ISIS) 9:46 a.m. Jan. 13, 2014 - TheStreet.com
Cramer's Lightning Round - I Can't Get My Arms Around The New Kodak (1/10/14) 6:29 a.m. Jan. 12, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I Don't Like Amgen 6:00 a.m. Jan. 11, 2014 - TheStreet.com
Isis Pharmaceuticals to Present at the Cowen 34th Annual Health Care Conference 7:00 a.m. Feb. 25, 2014 - PR Newswire - PRF
Critical Alerts For Cisco Systems, Michael Kors, Whole Foods Market, MetLife, and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Feb. 24, 2014 - PR Newswire - PRF
Brookdale Senior Living hits 5 year high on Emeritus Acquistion; eBay acquires PhiSix 12:26 a.m. Feb. 24, 2014 - ACCESSWIRE
Isis Pharmaceuticals Reports Interim Results from ISIS-SMN Rx Phase 2 Study in Infants with Spinal Muscular Atrophy 5:00 p.m. Feb. 21, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Reports Interim Results from ISIS-SMN Rx Multiple Dose Study in Children with Spinal Muscular Atrophy 7:00 a.m. Feb. 21, 2014 - PR Newswire - PRF
Webcast Alert: Isis Pharmaceuticals' 2013 Financial Results and Highlights Conference Call 5:01 p.m. Feb. 20, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the 2014 RBC Capital Markets Global Healthcare Conference 7:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Isis Announces Positive Opinion on European Orphan Drug Designation for ISIS-TTR Rx 1:32 p.m. Feb. 14, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Advances ISIS-SMN Rx in Infants and Children with Spinal Muscular Atrophy 7:00 a.m. Feb. 13, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the Leerink Global Healthcare Conference 7:00 a.m. Feb. 6, 2014 - PR Newswire - PRF
Joseph Loscalzo, M.D., Ph.D., Joins Isis Pharmaceuticals' Board of Directors 2:47 p.m. Feb. 3, 2014 - PR Newswire - PRF
RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics 10:06 a.m. Jan. 24, 2014 - ACCESSWIRE
Isis Pharmaceuticals to Receive $7.5 Million from Alnylam 4:30 p.m. Jan. 13, 2014 - PR Newswire - PRF
Critical Alerts For GM, Isis Pharmaceuticals, Boston Beer, MasterCard, and Macy's Released By InvestorsObserver 9:31 a.m. Jan. 13, 2014 - PR Newswire - PRF
Upcoming Presentations and Stock Price Movements - Research Report on Bard, Regeneron, Alexion, Seattle Genetics, and Isis Pharmaceuticals 8:00 a.m. Jan. 9, 2014 - PR Newswire
NIH Data Sharing Projects Could Accelerate RNAi Field 11:16 a.m. Jan. 8, 2014 - ACCESSWIRE
Isis Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference 7:00 a.m. Jan. 6, 2014 - PR Newswire
Market Technicals on Thursday: Quest Diagnostics, Santarus, Isis Pharma, and Community Health Systems 8:00 a.m. Dec. 26, 2013 - PR Newswire
Stock Price Movements of Healthcare Companies- Research Report on LabCorp, Isis Pharmaceuticals, Mindray, Clovis Oncology and Sangamo Biosciences 8:00 a.m. Dec. 23, 2013 - PR Newswire
Surgical Scar Market Is Ripe for Innovation 11:15 a.m. Dec. 18, 2013 - ACCESSWIRE
Health-care-related stocks keep on giving 12:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 12:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 11:59 a.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 10:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 2:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 9:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 10:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 2:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 10:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 4:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 5:18 p.m. June 25, 2013 - Russ Britt
Dissecting the close: Isis soars on data, while Pfizer loses on spin-off 6:26 p.m. June 24, 2013 - Russ Britt
3 ways to play the biotech boom 6:01 a.m. June 3, 2013 - Jeff Reeves
S&P 500 holds the 50-day average — barely 10:41 a.m. April 18, 2013 - Michael Ashbaugh
Biogen inks drug-development deal with Isis 2:06 p.m. Dec. 10, 2012 - MarketWatch.com
Isis: progress in early-stage study of cancer drug 7:53 a.m. Oct. 31, 2012 - MarketWatch.com
Isis Pharma rises 9% in premarket 6:22 a.m. Oct. 19, 2012 - Steve Gelsi
Investing in ‘junk DNA’ 9:28 p.m. Sept. 11, 2012 - Jen Wieczner
Growth Stocks: 7 Rallying Stocks With No Profits (Yeta????) 5:51 p.m. Feb. 24, 2014 - TheStreet.com
Isis Pharma Soars on Positive Data - Analyst Blog 1:30 p.m. Feb. 24, 2014 - Zacks.com
ISIS reiterated a Buy at Deutsche after data 11:03 a.m. Feb. 21, 2014 - Seeking Alpha
Isis therapy for spinal muscular atrophy provides encouraging results 7:41 a.m. Feb. 21, 2014 - Seeking Alpha
Isis Pharmaceuticals (ISIS): Today's Featured Drugs Laggard 5:01 p.m. Feb. 18, 2014 - TheStreet.com
Positive Opinion on Isis Pharma's ISIS-TTRRx - Analyst Blog 11:50 a.m. Feb. 18, 2014 - Zacks.com
Isis to get another $9M from Biogen 9:15 a.m. Feb. 13, 2014 - Seeking Alpha
Canadian Nod for Aegerion's Juxtapid - Analyst Blog 4:45 p.m. Feb. 11, 2014 - Zacks.com
OncoGenex Has A Potential Blockbuster Drug, But The Markets Are Pricing It Like An Orphan 9:25 a.m. Jan. 28, 2014 - Seeking Alpha
Jim Cramer's Top Stock Picks: ISIS JAZZ SYY ETH IBM 6:00 a.m. Jan. 28, 2014 - TheStreet.com
Cramer's Mad Money - We Are In Reset Mode (1/27/14) 5:06 a.m. Jan. 28, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Market Reset 8:33 p.m. Jan. 27, 2014 - TheStreet.com
Insider Trading Alert - PLUG, UNP, OPK, ISIS And MA Traded By Insiders 10:03 a.m. Jan. 27, 2014 - TheStreet.com
Mexican Approval for Aegerion's Juxtapid - Analyst Blog 4:20 p.m. Jan. 21, 2014 - Zacks.com
Isis Pharmaceuticals, Inc. (ISIS): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 21, 2014 - Zacks.com
Isis, Teledyne and Pandora Among Top Small-Cap Picks 6:00 a.m. Jan. 16, 2014 - TheStreet.com
Isis Pharma gets $7.5M from Alnylam 4:47 p.m. Jan. 13, 2014 - Seeking Alpha
New Lifetime High For Isis Pharmaceuticals (ISIS) 9:46 a.m. Jan. 13, 2014 - TheStreet.com
Cramer's Lightning Round - I Can't Get My Arms Around The New Kodak (1/10/14) 6:29 a.m. Jan. 12, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I Don't Like Amgen 6:00 a.m. Jan. 11, 2014 - TheStreet.com
Isis Pharmaceuticals to Present at the Cowen 34th Annual Health Care Conference 7:00 a.m. Feb. 25, 2014 - PR Newswire - PRF
Critical Alerts For Cisco Systems, Michael Kors, Whole Foods Market, MetLife, and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Feb. 24, 2014 - PR Newswire - PRF
Brookdale Senior Living hits 5 year high on Emeritus Acquistion; eBay acquires PhiSix 12:26 a.m. Feb. 24, 2014 - ACCESSWIRE
Isis Pharmaceuticals Reports Interim Results from ISIS-SMN Rx Phase 2 Study in Infants with Spinal Muscular Atrophy 5:00 p.m. Feb. 21, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Reports Interim Results from ISIS-SMN Rx Multiple Dose Study in Children with Spinal Muscular Atrophy 7:00 a.m. Feb. 21, 2014 - PR Newswire - PRF
Webcast Alert: Isis Pharmaceuticals' 2013 Financial Results and Highlights Conference Call 5:01 p.m. Feb. 20, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the 2014 RBC Capital Markets Global Healthcare Conference 7:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Isis Announces Positive Opinion on European Orphan Drug Designation for ISIS-TTR Rx 1:32 p.m. Feb. 14, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Advances ISIS-SMN Rx in Infants and Children with Spinal Muscular Atrophy 7:00 a.m. Feb. 13, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the Leerink Global Healthcare Conference 7:00 a.m. Feb. 6, 2014 - PR Newswire - PRF
Joseph Loscalzo, M.D., Ph.D., Joins Isis Pharmaceuticals' Board of Directors 2:47 p.m. Feb. 3, 2014 - PR Newswire - PRF
RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics 10:06 a.m. Jan. 24, 2014 - ACCESSWIRE
Isis Pharmaceuticals to Receive $7.5 Million from Alnylam 4:30 p.m. Jan. 13, 2014 - PR Newswire - PRF
Critical Alerts For GM, Isis Pharmaceuticals, Boston Beer, MasterCard, and Macy's Released By InvestorsObserver 9:31 a.m. Jan. 13, 2014 - PR Newswire - PRF
Upcoming Presentations and Stock Price Movements - Research Report on Bard, Regeneron, Alexion, Seattle Genetics, and Isis Pharmaceuticals 8:00 a.m. Jan. 9, 2014 - PR Newswire
NIH Data Sharing Projects Could Accelerate RNAi Field 11:16 a.m. Jan. 8, 2014 - ACCESSWIRE
Isis Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference 7:00 a.m. Jan. 6, 2014 - PR Newswire
Market Technicals on Thursday: Quest Diagnostics, Santarus, Isis Pharma, and Community Health Systems 8:00 a.m. Dec. 26, 2013 - PR Newswire
Stock Price Movements of Healthcare Companies- Research Report on LabCorp, Isis Pharmaceuticals, Mindray, Clovis Oncology and Sangamo Biosciences 8:00 a.m. Dec. 23, 2013 - PR Newswire
Surgical Scar Market Is Ripe for Innovation 11:15 a.m. Dec. 18, 2013 - ACCESSWIRE
(0)
(0)